跳至主要内容
临床试验/NCT05755490
NCT05755490已完成不适用

PROWESS (PROstate Cancer Wearables Exercise and Structured Supports): A Pilot Supportive Care Intervention

Massachusetts General Hospital2 个研究点 分布在 1 个国家目标入组 14 人开始时间: 2023年8月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
14
试验地点
2
主要终点
Participant Satisfaction

研究概览

简要总结

The goal of this research study is to conduct an open pilot of a behavioral change intervention called PROstate Cancer Wearables, Exercise, and Structured Supports (PROWESS) for integrating health behavior change tools and to increase exercise, reduce side effects of androgen deprivation therapy (ADT), and improve quality of life in Black and Hispanic/Latino men with prostate cancer.

The name of the intervention used in this research study is:

PROWESS (behavioral change intervention)

详细描述

This research study is to test a behavioral change intervention called PROstate Cancer Wearables, Exercise, and Structured Supports (PROWESS) for integrating health behavior change tools with wearable technology, to increase exercise, reduce side effects of androgen deprivation therapy (ADT), and improve quality of life in Black and Hispanic/Latino men with prostate cancer on androgen deprivation therapy (ADT).

Study procedures include screening for eligibility, intervention sessions, questionnaires and surveys, and an exit interview with study staff.

Participation in this research study is expected to last for up to four months.

The goal and primary outcome of this open pilot study is refinement of the intervention and study procedures to allow for us to conduct a larger feasibility study in the future.

It is expected that about 10 people will take part in this research study.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Diagnosed with prostate cancer.
  • Planning to be on androgen deprivation therapy (ADT) for at least three months
  • Black Race AND/OR Hispanic/Latino Ethnicity (confirmed by patient self-report)
  • Verbal fluency in English or Spanish.
  • Receiving ongoing oncology care at MGH Cancer Center.
  • Age ≥ 18 years.
  • Self-Report less than or equal to 150 minutes of moderate or vigorous structured exercise per week, as assessed by the Exercise is Medicine Physical Activity Vital Sign Assessment
  • Completion of baseline assessment

排除标准

  • Unwilling or unable to participate in the study.
  • Significant psychiatric, cognitive or other comorbid disease which the treating clinician believes prohibits informed consent or participation in the study.
  • Currently receiving chemotherapy.
  • Prognosis less than 6 months, per the judgment of the primary oncologist.
  • Medical contraindication to physical activity, as assessed by outpatient oncologist.

结局指标

主要结局

Participant Satisfaction

时间窗: At week 8-12 (intervention completion)

Assessed by the Client Satisfaction Questionnaire-3 (CSQ), a 3-item survey with answers ranging from 1-4, "quite dissatisfied" to "very satisfied."

次要结局

  • Change in Objective Physical Activity(At Baseline and from weeks 1 - 12)
  • Change in Self-Reported Exercise(At Baseline and weeks 8-12)
  • Change in Participant Quality of Life(At Baseline and weeks 8-12)
  • Change in Psychological Distress Symptoms(At Baseline and weeks 8-12)
  • Change in Self-Efficacy for Managing Symptoms(At Baseline and weeks 8-12)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Daniel E Lage, MD, MSc

Principal Investigator

Massachusetts General Hospital

研究点 (2)

Loading locations...

相似试验